You are currently viewing Understanding SIFO: Symptoms, Causes & SIBO Link

Understanding SIFO: Symptoms, Causes & SIBO Link

One estimate suggests small intestinal fungal overgrowth (SIFO) is present in 24% of people with small intestinal bacterial overgrowth (SIBO). This is a reported association, not a prediction for any individual, and SIFO can also occur without SIBO.

Ongoing bloating, abdominal discomfort or changes in bowel habits can be frustrating, especially when the cause is unclear.

In this article, we explain who may be more likely to develop SIFO, how it relates to SIBO, and what diagnosis and antifungal treatment involve. We’ll also consider the limits of current research evidence, so you can explore possible explanations without assuming one accounts for every symptom.

Key Takeaways

  • Learn which health and medication factors may be associated with fungal overgrowth, and why risk factors alone cannot confirm it.
  • Understand how medical antifungals and nutrition-led approaches differ, and why treatment evidence and recurrence need careful consideration.
  • Find out what small-bowel sampling can show, and why breath tests assess bacterial overgrowth rather than directly diagnosing fungal overgrowth.
  • Know which symptoms warrant a GP appointment and how digestive health testing and nutritional support may help you explore persistent concerns.

SIFO risk factors: who’s most vulnerable?

Small intestinal fungal overgrowth (SIFO) is associated with several factors, rather than one proven cause. What causes SIFO, and what are the risk factors? It may develop when gut defences or movement are disrupted. SIFO can occur alongside intestinal bacterial overgrowth, but neither condition proves the other is present.

Immune status may be relevant, but a weakened immune system is not necessary for SIFO. It has been reported in people with healthy immunity as well as those taking immunosuppressant medicines. Previous gastrointestinal surgery, including colectomy, may alter anatomy or gut function. These factors do not mean someone will inevitably develop SIFO.

Medicines are another consideration. Proton pump inhibitors (PPIs) reduce stomach acid and have been associated with SIFO, particularly with frequent or long-term use. Antibiotics can change the balance of gut microbes, potentially allowing fungi to flourish. Don’t stop or change prescribed medicines without speaking with your prescriber.

Motility is the coordinated movement that carries food through the digestive tract. Impaired motility may slow this movement and affect the small intestine’s microbial balance. Severe constipation or conditions affecting gut nerves may also be relevant to overgrowth risk, but they do not diagnose SIFO. Because bloating and abdominal discomfort occur in several digestive conditions, risk factors need to be considered alongside the wider clinical picture.

Antifungal treatment

Treatment options include nutrition-led approaches and prescription antifungals, but evidence specific to SIFO is limited. From a nutritionist’s standpoint, herbal supplements are usually the first recommendation. They are not a substitute for prescribed medical care. Risks depend on the treatment, and medicines may cause side effects or interactions, so medical oversight matters.

Conventional and herbal antifungals

Herbal antibiotics may be considered first as part of a nutrition-led approach, although evidence for their use specifically in SIFO remains limited. They are not a substitute for prescribed antifungals or other medical care. Conventional antifungal medicines, such as fluconazole, may be prescribed when testing identifies substantial fungal growth. In some cases, treatment is tried without definitive confirmation. Symptom improvement is not assured, and digestive symptoms may continue.

Treatment duration and recurrence

Treatment plans may vary, and follow-up can help assess symptoms and monitor for recurrence. The duration depends on the clinical picture and response. Symptoms can persist or return, since abdominal pain, bloating and diarrhoea may have other causes. A return of symptoms alone doesn’t establish recurrence; reassessment can help distinguish fungal overgrowth from another digestive issue.

Treatment options, risks and side effects

Probiotics, including Saccharomyces boulardii, have been proposed as another option, but evidence for SIFO is limited. They should not replace assessment or prescribed care. The possible risks of antifungal medicines depend on the medicine, a person’s health and other prescriptions. A clinician can review interactions and suitability, particularly if symptoms such as diarrhoea or abdominal pain persist.

How is SIFO diagnosed?

SIFO is generally defined as more than 1,000 fungal colony-forming units per mL of small-intestinal fluid. UK clinical guidance and NHS public information don’t set out a routine SIFO-specific diagnostic or treatment pathway. For ongoing digestive symptoms, the NHS advises seeking medical assessment rather than assuming a fungal cause.

A small-bowel aspirate is fluid collected during an endoscopy, often from the duodenum or jejunum. A laboratory can culture the sample to identify fungi and estimate their amount. This is the direct method described for confirming SIFO, but it requires an invasive procedure and samples only part of the small intestine. Contamination or sampling conditions may also affect how the result is interpreted.

Breath testing answers a different question. After a test drink, it measures gases such as hydrogen or methane produced by gut microbes. Clinicians use it to assess small intestinal bacterial overgrowth (SIBO), not fungal growth. A breath-test result therefore cannot confirm or rule out SIFO, even when symptoms overlap.

Stool tests primarily reflect fungi in the large intestine, rather than specifically identifying small-intestinal overgrowth. Urine arabinitol may indicate Candida activity, but cannot show where in the gut it originates. Test choice depends on the clinical question, symptoms and medical history. Discuss persistent symptoms with your GP, who can assess other possible causes and appropriate next steps. This helps avoid treating an indirect result as a definitive diagnosis.

SIFO prevalence in people with unexplained gastrointestinal symptoms

Research has found SIFO in selected groups with persistent digestive symptoms, but these findings do not establish how common it is in the wider population.

Prevalence in unexplained gastrointestinal symptoms

In one small study, around 25% of 150 people with unexplained gastrointestinal problems had SIFO. This result describes that particular group, not everyone with bloating or other digestive symptoms. It can help explain why fungal overgrowth may be considered during investigation, but it cannot predict an individual’s likelihood or show that SIFO is a common cause of unexplained symptoms.

Measuring the reported prevalence

Researchers assessed prevalence by collecting fluid from the small intestine and culturing it for fungi. The study’s estimate therefore depended on who was recruited, how samples were collected and how fungal growth was classified. These details matter when interpreting a percentage: findings from a selected group cannot automatically be applied to people with different symptoms or health histories.

SIFO without SIBO

SIFO may occur without small intestinal bacterial overgrowth (SIBO), but the study above does not establish how often it occurs in people without SIBO. The conditions can also overlap and share symptoms, including bloating, abdominal discomfort and bowel changes. In severe cases, SIFO may be associated with weight loss or nutrient deficiencies. Those signs have other possible causes, so symptoms alone cannot identify fungal overgrowth.

Understanding SIFO: Symptoms, Causes & SIBO Link

When to see your GP

Persistent digestive symptoms deserve attention, particularly when they change or affect daily life. Symptoms associated with SIFO can overlap with other conditions, so don’t assume a fungal cause without medical assessment.

Contact your GP about any of the following:

  • Blood in your stool, unexplained weight loss or persistent vomiting.
  • Difficulty swallowing or anaemia.
  • Digestive symptoms that wake you at night.
  • A family history of bowel cancer or coeliac disease.
  • A new, persistent change in bowel habit, especially if you’re over 50.

These symptoms do not point to one diagnosis on their own. Your GP can assess your history and decide whether an examination or further investigation is appropriate. Mention when symptoms began, how they have changed and any medicines you take. This context can help make the appointment more useful.

Before making significant dietary changes, speak with your GP about ruling out coeliac disease and other medical conditions. Restrictive changes can affect nutrition and may complicate assessment, so it is sensible to establish what needs investigating first. Don’t stop prescribed medicines without discussing them with your prescriber.

If you’re already receiving medical care and want help understanding the nutritional aspects of ongoing digestive symptoms, our consultation process explains how one-to-one support can sit alongside your GP or consultant. This support doesn’t replace medical assessment, especially when any of the warning signs above are present.

IBS Clinics: hydrogen breath tests for SIBO

IBS Clinics offers hydrogen breath tests to assess small intestinal bacterial overgrowth (SIBO). The test measures gases, including hydrogen, in your breath after a test drink. It can help investigate bacterial activity, but it does not detect fungi or confirm small intestinal fungal overgrowth (SIFO).

This distinction matters if you’re considering testing for persistent bloating, abdominal discomfort or altered bowel habits. A breath-test result needs to be understood alongside your symptoms and health history. It can inform a discussion about SIBO, but cannot establish that SIFO is present or explain every digestive symptom.

IBS Clinics offers gut health tests and IBS care for people with complex or ongoing digestive concerns, provided by registered nutritionists. The right assessment depends on the question being explored. Testing is one part of understanding the wider picture, not a stand-alone answer or a substitute for medical assessment when symptoms need a GP’s attention.

If you’re unsure which questions to ask, an introductory chat gives you space to talk through your situation and understand the available support. The free 15-minute chat is an opportunity to ask questions without committing to a particular test or approach. Appointments are held over Zoom for people across the UK.

Book a free 15-minute introductory chat with IBS Clinics to talk through your questions.

Choose a thoughtful next step

Persistent digestive symptoms can leave you searching for one clear explanation. Yet the possibility of SIFO, or small intestinal fungal overgrowth, needs to be considered in the context of your health, symptoms and appropriate clinical assessment. You don’t need to settle on a cause before asking for support.

If you’re weighing up what to do next, a conversation can help you organise your questions and decide what feels useful to explore. IBS Clinics offers a free 15-minute introductory chat, alongside gut health tests and IBS care. These options can support a more considered discussion of your digestive health, while your GP remains the right person to assess concerning symptoms or medical needs.

You don’t need to have every detail worked out before reaching out. Start with the concerns that matter most to you, and take the next step at a pace that feels manageable.

Talk with IBS Clinics about your symptoms. A clearer conversation can be a helpful place to begin.

Frequently asked questions

Who can have SIFO?

Anyone may develop small intestinal fungal overgrowth (SIFO), including people with healthy immune systems. It has also been associated with factors such as certain medicines, previous gastrointestinal surgery and disrupted gut movement. These associations do not mean SIFO is present or that someone will develop it. A risk factor can inform a medical conversation, but cannot replace assessment of symptoms and health history.

Can SIFO lead to other health issues?

In severe cases, SIFO has been associated with weight loss or nutrient deficiencies. These findings can also arise from other digestive or medical conditions, so they do not identify SIFO by themselves. If you’re losing weight without trying or are concerned about a possible deficiency, speak with your GP. They can consider appropriate investigations rather than relying on a suspected fungal cause alone.

How do you know if you have SIBO?

Symptoms alone can’t establish small intestinal bacterial overgrowth (SIBO). A clinician may consider a breath test, which measures gases after you drink a prepared solution, alongside your symptoms and medical history. The test assesses gas patterns associated with bacterial activity; it doesn’t directly show bacteria in the small intestine. Your GP can help assess persistent symptoms and whether further investigation is appropriate.

What are the symptoms?

SIFO and SIBO can both be associated with bloating, abdominal discomfort and changes in bowel habits, making symptoms difficult to distinguish. None of these experiences is specific to either condition. Keeping a brief record of when symptoms occur, how they affect daily activities and any relevant medication changes can help you describe the pattern clearly during a medical appointment.

What causes SIBO?

SIBO is associated with changes that affect the small intestine’s normal movement or structure. For example, previous abdominal surgery may alter intestinal anatomy, while severe constipation can be relevant to slower gut transit. These are possible contributing factors, not proof of overgrowth. A clinician considers them alongside symptoms and medical history when deciding what assessment may be useful.

What is small intestinal fungal overgrowth (SIFO)?

SIFO describes an increased amount of fungi in the small intestine, rather than fungal presence elsewhere in the digestive tract. Candida species are commonly involved, but finding Candida in stool doesn’t establish small-intestinal overgrowth. Stool samples mainly reflect the large intestine. This distinction matters because a test result needs to answer the specific clinical question being considered.

Tracey Randell

Article by

Tracey Randell

Tracey Randell is a Registered Nutritionist and IFM Certified Practitioner (Dip BCNH, IFMCP, mBANT, CNHC), specialising in complex digestive health. She founded IBS Clinics in 2011 and has spent more than 15 years supporting people with SIBO, IMO, SIFO, dysbiosis and long-standing IBS, many of whom have tried several approaches without lasting improvement.

Tracey’s approach is terrain-first. She looks beyond symptoms to the whole gut environment, including digestion, motility, the microbiome, blood sugar and stress. She works with clients across the UK via Zoom, alongside GPs and consultants where appropriate.

Leave a Reply